Targeting mitochondrial ROS with mito‐TEMPO restores T cell function, highlighting a potential therapeutic strategy for immune restoration in HIV infection.[49] While the role of redox homeostasis in CD8+ T cell function is increasingly appreciated, current studies often fail to delineate the boundary between physiological ROS signaling and pathological oxidative stress. Here, CD8A is linked to HIV infectious disease.